Biomind Labs
C$0.5
2
+C$0.03+6.38% Friday 14:38
Statistik
Harga Tertinggi Hari
0.5
Harga Terendah Hari
0.5
52M Tertinggi
1.09
52M Terendah
0.03
Volum
3,000
Volum Purata
1,653
Kapasiti Pasaran
44.86M
Nisbah P/E
-
Pendapatan Dividen
-
Dividen
-
Dividen
0%Pendapatan Dividen
Pertumbuhan 10T
N/A
Pertumbuhan 5T
N/A
Pertumbuhan 3T
N/A
Pertumbuhan 1T
N/A
Orang Lain Juga Mengikuti
Senarai ini berdasarkan senarai pantau orang di Stock Events yang mengikuti BMND.NEO. Ini bukan cadangan pelaburan.
Peserta
Senarai ini adalah analisis berdasarkan peristiwa pasaran terkini. Ini bukan cadangan pelaburan.
Compass Pathways
CMPS
Kapasiti Pasaran511.54M
Mind Medicine
MNMD
Kapasiti Pasaran493.47M
ATAI Life Sciences N.V.
ATAI
Kapasiti Pasaran218.14M
GH Research
GHRS
Kapasiti Pasaran546.3M
Cybin
CYBN
Kapasiti Pasaran194.47M
Revive Therapeutics
RVVTF
Kapasiti Pasaran3.99M
Mydecine Innovations
MYCOF
Kapasiti Pasaran649,542
Mengenai
Biomind Labs Inc., a biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions. The company is developing BMND01, which is in Phase II clinical trials for use in the treatment of depression; and BMND08, a 5-Methoxy-N,N-dimethyltryptamine based candidate that is in Phase II clinical trials for treatment of depression and anxiety in patients with Alzheimer's-type cognitive impairment. It is also developing new and preclinical drug candidates, including BMND02 for treating fibromyalgia, BMND03 for treating addictive disorders, BMND05 for treating chronic pain, BMND06 for treating inflammatory disorders, and BMND07 for treating major depressive disorder. The company is headquartered in Canelones, Uruguay.
Show more...
CEO
Mr. Alejandro Antalich
Pekerja
5
Negara
CA
ISIN
CA0907021012